BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3117112)

  • 1. 5'-modified agonist and antagonist (2'-5')(A)n analogues: synthesis and biological activity.
    Bisbal C; Silhol M; Lemaître M; Bayard B; Salehzada T; Lebleu B; Perrée TD; Blackburn MG
    Biochemistry; 1987 Aug; 26(16):5172-8. PubMed ID: 3117112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatic synthesis, properties, and biological activities of 2',5'-phosphorothioates from adenosine 5'-O-(2-thiotriphosphate) and adenosine 5'-O-(3-thiotriphosphate).
    Suhadolnik RJ; Lee C; Karikó K; Li SW
    Biochemistry; 1987 Nov; 26(22):7143-9. PubMed ID: 3427064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorothioate analogues of 2',5'-oligoadenylate. Enzymatically synthesized 2',5'-phosphorothioate dimer and trimer: unequivocal structural assignment and activation of 2',5'-oligoadenylate-dependent endoribonuclease.
    Karikó K; Sobol RW; Suhadolnik L; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7127-35. PubMed ID: 3427062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of ribonuclease L by (2'-5')(A)4-poly(L-lysine) conjugates in intact cells.
    Bayard B; Bisbal C; Lebleu B
    Biochemistry; 1986 Jun; 25(12):3730-6. PubMed ID: 3013297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorothioate analogues of 2',5'-oligoadenylate. Activation of 2',5'-oligoadenylate-dependent endoribonuclease by 2',5'-phosphorothioate cores and 5'-monophosphates.
    Karikó K; Li SW; Sobol RW; Suhadolnik RJ; Charubala R; Pfleiderer W
    Biochemistry; 1987 Nov; 26(22):7136-42. PubMed ID: 3427063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of tubercidin analogues of ppp5'A2'p(5'A2'p)n5'A.
    Jamoulle JC; Imai J; Lesiak K; Torrence PF
    Biochemistry; 1984 Jun; 23(13):3063-9. PubMed ID: 6466631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of a fluorescent analogue of 2-5A.
    Lesiak K; Torrence PF
    FEBS Lett; 1983 Jan; 151(2):291-6. PubMed ID: 6832358
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral activity in L1210 cells of liposome-encapsulated (2'-5')oligo(adenylate) analogues.
    Bayard B; Leserman LD; Bisbal C; Lebleu B
    Eur J Biochem; 1985 Sep; 151(2):319-25. PubMed ID: 2992962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respective role of each of the purine N7 nitrogens of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine in binding to and activation of the RNase L of mouse cells.
    Jamoulle JC; Lesiak K; Torrence PF
    Biochemistry; 1987 Jan; 26(2):376-83. PubMed ID: 3030408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2'5' Oligoadenylate analogues:synthesis, biological activities and intracellular delivery.
    Bisbal C; Bayard B; Silhol M; Leserman L; Lebleu B
    Prog Clin Biol Res; 1985; 202():89-95. PubMed ID: 3008175
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of HIV-1 replication and activation of RNase L by phosphorothioate/phosphodiester 2',5'-oligoadenylate derivatives.
    Sobol RW; Henderson EE; Kon N; Shao J; Hitzges P; Mordechai E; Reichenbach NL; Charubala R; Schirmeister H; Pfleiderer W
    J Biol Chem; 1995 Mar; 270(11):5963-78. PubMed ID: 7890727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, characterization, and biological properties of 8-azido- and 8-amino-substituted 2',5'-oligoadenylates.
    Sawai H; Hirano A; Mori H; Shinozuka K; Dong B; Silverman RH
    J Med Chem; 2003 Nov; 46(23):4926-32. PubMed ID: 14584943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of oligo(8-bromoadenylates) as analogues of 5'-O-triphosphoadenylyl(2'----5')adenylyl(2'----5')adenosine.
    Lesiak K; Torrence PF
    J Med Chem; 1986 Jun; 29(6):1015-22. PubMed ID: 3712372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2',5'-Oligoadenylates chiral at phosphorus: enzymatic synthesis, properties, and biological activities of 2',5'-phosphorothioate trimer and tetramer analogues synthesized from (SP)-ATP alpha S.
    Lee C; Suhadolnik RJ
    Biochemistry; 1985 Jan; 24(3):551-5. PubMed ID: 3994975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorothioate and cordycepin analogues of 2',5'-oligoadenylate: inhibition of human immunodeficiency virus type 1 reverse transcriptase and infection in vitro.
    Montefiori DC; Sobol RW; Li SW; Reichenbach NL; Suhadolnik RJ; Charubala R; Pfleiderer W; Modliszewski A; Robinson WE; Mitchell WM
    Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7191-4. PubMed ID: 2476814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of murine RNase L by isopolar 2'-phosphonate analogues of 2',5' oligoadenylates.
    Pav O; Protivinska E; Pressova M; Collinsova M; Jiracek J; Snasel J; Masojidkova M; Budesinsky M; Rosenberg I
    J Med Chem; 2006 Jun; 49(13):3955-62. PubMed ID: 16789752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2',5'-Oligoadenylates and related 2',5'-oligonucleotide analogues. 2. Effect on cellular proliferation, protein synthesis, and endoribonuclease activity.
    Hughes BG; Robins RK
    Biochemistry; 1983 Apr; 22(9):2127-35. PubMed ID: 6860653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5'-Phosphonate modified oligoadenylates as potent activators of human RNase L.
    Lášek T; Petrová M; Košiová I; Šimák O; Buděšínský M; Kozák J; Snášel J; Vavřina Z; Birkuš G; Rosenberg I; Páv O
    Bioorg Med Chem; 2022 Feb; 56():116632. PubMed ID: 35078032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical synthesis of an effective inhibitor of protein synthesis in eukaryotic cells: pppA2'-5'A2'-5'A and some analogues.
    den Hartog JA; Wijnands RA; van Boom JH; Crea R
    Nucleic Acids Symp Ser; 1980; (7):157-66. PubMed ID: 7255167
    [No Abstract]   [Full Text] [Related]  

  • 20. Solid-phase synthesis of 5'-triphosphate 2'-5'-oligoadenylates analogs with 3'-O-biolabile groups and their evaluation as RNase L activators and antiviral drugs.
    Thillier Y; Stevens SK; Moy C; Taylor J; Vasseur JJ; Beigelman L; Debart F
    Bioorg Med Chem; 2013 Sep; 21(17):5461-9. PubMed ID: 23810677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.